Patients with ERα-positive ovarian cancer account for more than 60% of ovarian cancer patients [3], and there is no complete understanding of its pathogenesis, but it is believed to be associated with hormone signaling and estrogen. This evidence concerns the gene ESR1 and ovarian carcinoma.